Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology (Q37391968)

20 August 2017

1 reference

title

Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology (English)

1 reference

20 August 2017

1 reference

1 reference

Jun Ren

1

1 reference

PubMed ID

19214173

20 August 2017

Robert O Kelley

series ordinal

2

1 reference

20 August 2017

12 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

17

1 reference

20 August 2017

6

1 reference

20 August 2017

1114-1123

1 reference

IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes

20 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Estrogen replacement therapy and cardioprotection: mechanisms and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Metabolic obesity: the paradox between visceral and subcutaneous fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Diabetic kidney disease: impact of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Time- and dose-dependent differential upregulation of three genes by 17 beta-estradiol in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Estrogen, NFkappaB, and the heat shock response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Cardiovascular disease and modifiable cardiometabolic risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

31 March 2020

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Diabetic cardiomyopathy: do women differ from men?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Altered cardiac excitation-contraction coupling in ventricular myocytes from spontaneously diabetic BB rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

The cardiometabolic syndrome and calcium channel blocker combination drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Insights into the emerging cardiometabolic prevention and management of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Benefit and risk of exercise on myocardial function in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Diabetes and the menopause

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Hypogonadism and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

[Diabetic cardiopathy: pathogenesis, diagnosis and therapy].

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Obesity, diabetes, and risk of cardiovascular disease in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Evidence-based guidelines for cardiovascular disease prevention in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Prevention of heart disease in women: recommendations for management of risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Tracking women's awareness of heart disease: an American Heart Association national study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sex differences in congenital heart disease: should a woman be more like a man?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

The influence of gender, diabetes, and acetaldehyde on the intrinsic contractile properties of isolated rat myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Influence of gender and diabetes on vascular and myocardial contractile function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sex differences in myocardial contractility in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Diabetes mellitus and cardiovascular disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Role of gender in heart failure with normal left ventricular ejection fraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender disparity of streptozotocin-induced intrinsic contractile dysfunction in murine ventricular myocytes: role of chronic activation of Akt.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Influence of gender on intrinsic contractile properties of isolated ventricular myocytes from calmodulin-induced diabetic transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender-specific effect of metabolic syndrome on rate adjusted QT interval in middle-aged participants of an atherosclerosis prevention program.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Comparison of cardiac contractile and intracellular Ca2+ response between estrogen and phytoestrogen alpha-zearalanol in ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Acute actions of testosterone on contractile function of isolated rat ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

The rise and fall of menopausal hormone therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

The women's health initiative reports in perspective: facts or fallacies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Metabolic Risks among College Students: Prevalence and Gender Differences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Comparative associations of adiposity measures with cardiometabolic risk burden in asymptomatic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Antidiabetic actions of estrogen: insight from human and genetic mouse models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Cardiomyocyte dysfunction in insulin-resistant rats: a female advantage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Biochemistry and molecular cell biology of diabetic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sexual dimorphism in human lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender-dependent effect of ageing on peripheral insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender, a significant factor in the cross talk between genes, environment, and health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Association analysis of genes in the renin-angiotensin system with subclinical cardiovascular disease in families with Type 2 diabetes mellitus: The Diabetes Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

31 March 2020

Cause of death: suicide

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Induction of calcium-dependent nitric oxide synthases by sex hormones.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Regulation of cell size and contractile function by AKT in cardiomyocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Myocardial Akt activation and gender: increased nuclear activity in females versus males

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Akt1 in the cardiovascular system: friend or foe?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Effects of chronic Akt activation on glucose uptake in the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Another role for the celebrity: Akt and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Impact of gender on basal and insulin-like growth factor I-regulated nitric oxide synthase activity in adult rat left ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of ma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender differences in the metabolic syndrome and their role for cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Metabolic syndrome after menopause and the role of hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Causes and metabolic consequences of Fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Leptin and hyperleptinemia - from friend to foe for cardiovascular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

The good fat hormone: adiponectin and cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Serum adiponectin concentration and cardiovascular risk factors in climacteric women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Immunogenetics, gender, and longevity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Plasma resistin levels correlate with determinants of the metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

After the Women's Health Initiative: decision making and trust of women taking hormone therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Gender differences in the regulation of vascular tone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2009.8

1 reference

20 August 2017

1 reference

PubMed ID

19214173